rs146422285
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001161403.3(LIMS2):āc.752A>Gā(p.Gln251Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000576 in 1,613,230 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001161403.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LIMS2 | NM_001161403.3 | c.752A>G | p.Gln251Arg | missense_variant, splice_region_variant | 7/10 | ENST00000355119.9 | NP_001154875.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIMS2 | ENST00000355119.9 | c.752A>G | p.Gln251Arg | missense_variant, splice_region_variant | 7/10 | 1 | NM_001161403.3 | ENSP00000347240 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152070Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000374 AC: 94AN: 251192Hom.: 0 AF XY: 0.000464 AC XY: 63AN XY: 135752
GnomAD4 exome AF: 0.000606 AC: 885AN: 1461042Hom.: 0 Cov.: 31 AF XY: 0.000631 AC XY: 459AN XY: 726874
GnomAD4 genome AF: 0.000296 AC: 45AN: 152188Hom.: 0 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74432
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2W Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | May 23, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 01, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 275 of the LIMS2 protein (p.Gln275Arg). This variant is present in population databases (rs146422285, gnomAD 0.07%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with LIMS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 542251). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.824A>G (p.Q275R) alteration is located in exon 7 (coding exon 7) of the LIMS2 gene. This alteration results from a A to G substitution at nucleotide position 824, causing the glutamine (Q) at amino acid position 275 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at